These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 33878313)
1. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma. Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
4. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment. Chen X; Ye Q; Chen Z; Lin Q; Chen W; Xie C; Wang X Bioengineered; 2022 May; 13(5):12237-12247. PubMed ID: 35579449 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis. Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663 [TBL] [Abstract][Full Text] [Related]
7. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis. Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer. Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
10. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1. Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
12. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Lan T; Yuan K; Yan X; Xu L; Liao H; Hao X; Wang J; Liu H; Chen X; Xie K; Li J; Liao M; Huang J; Zeng Y; Wu H Cancer Res; 2019 Jul; 79(13):3220-3234. PubMed ID: 31101763 [TBL] [Abstract][Full Text] [Related]
14. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo. Sun X; Zheng G; Li C; Liu C Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133 [TBL] [Abstract][Full Text] [Related]
17. Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma. Jewell ML; Gibson JR; Guy CD; Hyun J; Du K; Oh SH; Premont RT; Hsu DS; Ribar T; Gregory SG; Diehl AME Am J Pathol; 2020 Jan; 190(1):93-107. PubMed ID: 31669305 [TBL] [Abstract][Full Text] [Related]
18. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Xie X; Xu X; Sun C; Yu Z Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653 [TBL] [Abstract][Full Text] [Related]
19. The Prognostic Biomarker RAB7A Promotes Growth and Metastasis of Liver Cancer Cells by Regulating Glycolysis and YAP1 Activation. Zhang JY; Zhu X; Liu Y; Wu X J Cell Biochem; 2024 Aug; 125(8):e30621. PubMed ID: 38924128 [TBL] [Abstract][Full Text] [Related]
20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]